羟甲叔丁肾上腺素与阿替洛尔对哮喘患者通气及血流动力学影响的比较研究。
A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients.
作者信息
Lammers J W, Müller M E, Folgering H T, van Herwaarden C L
出版信息
Br J Clin Pharmacol. 1986 Nov;22(5):595-602. doi: 10.1111/j.1365-2125.1986.tb02940.x.
Abstract
The effects of single oral doses of atenolol 50 mg and xamoterol 200 mg (a recently developed partial beta 1-adrenoceptor agonist) on lung function, heart rate and blood pressure were investigated in 11 patients with asthma. Xamoterol caused a significant increase in heart rate and systolic blood pressure, which changes are consistent with the partial beta 1-adrenoceptor agonist activity of this drug. Atenolol induced a significant decrease in FEV1 and the forced vital capacity (FVC); there was a non-significant change in FEV1 and FVC after xamoterol. There was no significant difference between the effects of atenolol and xamoterol of FEV1 and FVC. Bronchospasm induced by atenolol 50 mg and xamoterol 200 mg was completely reversed by inhalation of the beta 2-adrenoceptor agonist terbutaline to a cumulative dose of 4.0 mg.
摘要
在11例哮喘患者中研究了单次口服50毫克阿替洛尔和200毫克扎莫特罗（一种最近研发的β1肾上腺素能受体部分激动剂）对肺功能、心率和血压的影响。扎莫特罗导致心率和收缩压显著升高，这些变化与该药物的β1肾上腺素能受体部分激动剂活性一致。阿替洛尔使第一秒用力呼气量（FEV1）和用力肺活量（FVC）显著降低；扎莫特罗给药后FEV1和FVC有不显著变化。阿替洛尔和扎莫特罗对FEV1和FVC的影响之间无显著差异。吸入累计剂量达4.0毫克的β2肾上腺素能受体激动剂特布他林可完全逆转50毫克阿替洛尔和200毫克扎莫特罗诱发的支气管痉挛。
相似文献
1
A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients.羟甲叔丁肾上腺素与阿替洛尔对哮喘患者通气及血流动力学影响的比较研究。
Br J Clin Pharmacol. 1986 Nov;22(5):595-602. doi: 10.1111/j.1365-2125.1986.tb02940.x.
2
Ventilatory effects of atenolol and bevantolol in asthma.阿替洛尔和贝凡洛尔对哮喘的通气作用
Clin Pharmacol Ther. 1985 Oct;38(4):428-33. doi: 10.1038/clpt.1985.199.
3
Effects of xamoterol (ICI 118,587) in asthmatic patients.羟甲特罗（ICI 118,587）对哮喘患者的影响。
Br J Clin Pharmacol. 1984 Oct;18(4):597-601. doi: 10.1111/j.1365-2125.1984.tb02510.x.
4
Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
Br J Clin Pharmacol. 1989;28 Suppl 1(Suppl 1):73S-74S. doi: 10.1111/j.1365-2125.1989.tb03578.x.
5
Assessment of the relative safety of the beta-blockers ICI 141,292 and atenolol in patients with bronchial asthma.支气管哮喘患者中β受体阻滞剂ICI 141,292和阿替洛尔相对安全性的评估。
Eur J Clin Pharmacol. 1986;30(6):653-8. doi: 10.1007/BF00608211.
6
Ventilatory and haemodynamic effects of terbutaline infusion during beta 1-selective blockade with metoprolol and acebutolol in asthmatic patients.在哮喘患者中，使用美托洛尔和醋丁洛尔进行β1选择性阻滞时静脉输注特布他林的通气和血流动力学效应。
Eur J Clin Pharmacol. 1982;23(3):203-8. doi: 10.1007/BF00547554.
7
Cardioselectivity of atenolol and metoprolol. A study in asthmatic patients.
Eur J Respir Dis. 1981 Dec;62(6):396-404.
8
Effect of atenolol on ventilatory and cardiac function in asthma.阿替洛尔对哮喘患者通气和心脏功能的影响。
Br Med J. 1976 Aug 21;2(6033):453-5. doi: 10.1136/bmj.2.6033.453.
9
Comparison of the effects of xamoterol, atenolol and propranolol on breathlessness, fatigue and plasma electrolytes during exercise in healthy volunteers.健康志愿者运动期间，比较羟甲异丁肾上腺素、阿替洛尔和普萘洛尔对呼吸急促、疲劳及血浆电解质的影响。
Eur J Clin Pharmacol. 1991;41(1):51-5. doi: 10.1007/BF00280106.
10
Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline.控释美托洛尔与阿替洛尔在哮喘患者中的比较：与特布他林的相互作用
Eur J Clin Pharmacol. 1988;33 Suppl:S25-32. doi: 10.1007/BF00578409.
引用本文的文献
1
Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.β 受体阻滞剂的演进：从抗心绞痛药物到配体定向信号转导。
Trends Pharmacol Sci. 2011 Apr;32(4):227-34. doi: 10.1016/j.tips.2011.02.010. Epub 2011 Mar 21.
2
Cardioselective beta-blocker use in patients with reversible airway disease.可逆性气道疾病患者使用心脏选择性β受体阻滞剂。
Cochrane Database Syst Rev. 2001;2002(2):CD002992. doi: 10.1002/14651858.CD002992.
3
Xamoterol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.Xamoterol。对其药效学、药代动力学特性及治疗用途的初步综述。
Drugs. 1988 Oct;36(4):455-74. doi: 10.2165/00003495-198836040-00004.
4
Long-term studies with xamoterol in heart failure.关于xamoterol治疗心力衰竭的长期研究。
Br J Clin Pharmacol. 1989;28 Suppl 1(Suppl 1):53S-58S. doi: 10.1111/j.1365-2125.1989.tb03573.x.
5
Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?β-肾上腺素能受体部分激动剂：心血管治疗的复兴？
Br J Clin Pharmacol. 1990 Aug;30(2):157-71. doi: 10.1111/j.1365-2125.1990.tb03760.x.
6
Is xamoterol safe in chronic airflow obstruction?羟甲异丁肾上腺素在慢性气流阻塞中使用安全吗？
Eur J Clin Pharmacol. 1992;42(2):147-50. doi: 10.1007/BF00278474.
本文引用的文献
1
EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS.β-肾上腺素能阻滞剂普萘洛尔对哮喘患者的影响。
Lancet. 1964 Nov 21;2(7369):1101-2. doi: 10.1016/s0140-6736(64)92617-0.
2
Deposition of pressurized suspension aerosols inhaled through extension devices.通过延长装置吸入的加压悬浮气雾剂的沉积。
Am Rev Respir Dis. 1981 Sep;124(3):317-20. doi: 10.1164/arrd.1981.124.3.317.
3
Cardioselectivity of atenolol in asthmatic patients.阿替洛尔在哮喘患者中的心脏选择性
Eur J Clin Pharmacol. 1981;21(3):173-6. doi: 10.1007/BF00627916.
4
Comparison of functional beta-adrenoceptor heterogeneity in central and peripheral airway smooth muscle of guinea pig and man.豚鼠与人的中枢和外周气道平滑肌中功能性β-肾上腺素能受体异质性的比较。
J Recept Res. 1983;3(1-2):89-106. doi: 10.3109/10799898309041925.
5
The effects of ICI 118,587 and atenolol on the responses to exercise and on breathlessness in healthy subjects.ICI 118,587和阿替洛尔对健康受试者运动反应及呼吸困难的影响。
Br J Clin Pharmacol. 1984 Jan;17(1):37-41. doi: 10.1111/j.1365-2125.1984.tb04996.x.
6
Ventilatory effects of beta 1-receptor-selective blockade with bisoprolol and metoprolol in asthmatic patients.比索洛尔和美托洛尔对哮喘患者β1受体选择性阻滞的通气效应
Eur J Clin Pharmacol. 1984;27(2):141-5. doi: 10.1007/BF00544036.
7
Comparison of the beta 1 selective affinity of prenalterol and corwin demonstrated by radioligand binding.通过放射性配体结合法对普瑞特罗和可文的β1选择性亲和力进行比较。
Eur J Pharmacol. 1984 Mar 2;98(3-4):407-12. doi: 10.1016/0014-2999(84)90289-9.
8
Effects of a cardioselective beta 1 partial agonist (corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction.一种心脏选择性β1部分激动剂（考温）对既往心肌梗死患者左心室功能和心肌代谢的影响。
Am J Cardiol. 1983 May 1;51(8):1267-74. doi: 10.1016/0002-9149(83)90297-7.
9
Ventilatory and haemodynamic effects of prenalterol and terbutaline in asthmatic patients.普瑞特罗和特布他林对哮喘患者通气及血流动力学的影响
Eur J Clin Pharmacol. 1983;24(2):173-8. doi: 10.1007/BF00613813.
10
Effect of prenalterol in asthmatic patients.普瑞特罗对哮喘患者的影响。
Eur J Clin Pharmacol. 1982 Oct;23(4):297-302. doi: 10.1007/BF00613609.
Zotero 插件